Literature DB >> 19272405

Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000).

Marc Arbyn1, Cindy Simoens, Herman Van Oyen, Jean-Michel Foidart, Frédéric Goffin, Philippe Simon, Valérie Fabri.   

Abstract

OBJECTIVE: Cervical cancer screening by surveys overestimate coverage because of selection and reporting biases.
METHODS: The prepared Inter-Mutualistic Agency dataset has about 13 million records from Pap smears, colposcopies, cervical biopsies and surgery, performed in Belgium between 1996 and 2000. Cervical cancer screening coverage was defined as the proportion of the target population (women of 25-64 years) that has had a Pap smear taken within the last 3 years. Proportions and incidence rates were computed using official population data of the corresponding age group, area and calendar year.
RESULTS: Cervical cancer screening coverage, in the period 1998-2000, was 59% at national level, for the target age group 25-64 years. Differences were small between the 3 regions. Variation ranged from 39% to 71%. Coverage was 64% for 25-29 year old women, 67% for those aged 30-39 years, 56% for those aged 50-54. The modal screening interval was 1 year. In the 3-year period 1998-2000, 3 million smears were taken from the 2.7 million women in the age group 25-64. Only 1.6 million women of the target group got one or more smears in that period and 1.1 million women had no smears, corresponding to an average of 1.88 smears per woman.
CONCLUSION: Coverage reached only 59%, but the number of smears used was sufficient to cover more than 100% of the target population. Structural reduction of overuse and extension of coverage is warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19272405     DOI: 10.1016/j.ypmed.2009.02.021

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  Awareness of HPV and Cervical Cancer Prevention Among University Health Sciences Students in Cyprus.

Authors:  Paraskevi A Farazi; Mohammad Siahpush; Tzeyu L Michaud; Jungyoon Kim; Chenai Muchena
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

2.  Knowledge Adequacy on Cervical Cancer Among African Refugee and Non-Refugee Women in Brisbane, Australia.

Authors:  Judith A Anaman; Ignacio Correa-Velez; Julie King
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

3.  Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Authors:  Lieven Annemans; Vanessa Rémy; James Oyee; Nathalie Largeron
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Authors:  Geert Zegels; Geert Aa Van Raemdonck; Wiebren Aa Tjalma; Xaveer Wm Van Ostade
Journal:  Proteome Sci       Date:  2010-12-08       Impact factor: 2.480

5.  Predictors of low cervical cancer screening among immigrant women in Ontario, Canada.

Authors:  Aisha K Lofters; Rahim Moineddin; Stephen W Hwang; Richard H Glazier
Journal:  BMC Womens Health       Date:  2011-05-27       Impact factor: 2.809

6.  Personal factors influence use of cervical cancer screening services: epidemiological survey and linked administrative data address the limitations of previous research.

Authors:  Sarah C Olesen; Peter Butterworth; Patricia Jacomb; Robert J Tait
Journal:  BMC Health Serv Res       Date:  2012-02-14       Impact factor: 2.655

7.  The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.

Authors:  Andrzej Nowakowski; Marek Cybulski; Andrzej Śliwczyński; Arkadiusz Chil; Zbigniew Teter; Przemysław Seroczyński; Marc Arbyn; Ahti Anttila
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

8.  A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium.

Authors:  W A A Tjalma; X B Trinh; M Rosenlund; A P Makar; F Kridelka; D Rosillon; P A Van Dam; S Collas De Souza; K Holl; P Simon; D Jenkins
Journal:  Facts Views Vis Obgyn       Date:  2015

9.  Challenges in the Prevention of Cervical Cancer in Romania.

Authors:  Raluca Dania Todor; Gabriel Bratucu; Marius Alexandru Moga; Adina Nicoleta Candrea; Luigi Geo Marceanu; Costin Vlad Anastasiu
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

10.  Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).

Authors:  Marc Arbyn; Valérie Fabri; Marleen Temmerman; Cindy Simoens
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.